Dermatology marketing isn’t one funnel. Medical derm is urgent, search-driven, and trust-gated; cosmetic derm is discretionary, premium, and reputation-driven. The practices that grow run both deliberately, because the channels that win each one are different and the patient who comes for a skin check is often the same patient who returns for Botox.
A patient looking for a skin-cancer screening and a patient researching injectables are in two different states of mind, but they make the same first move: they search, they read reviews, and they judge your practice before anyone picks up the phone. BrightLocal finds that 97% of consumers read reviews for local businesses, and 68% will only use a business rated four stars or higher. Whatever brought them in, your visibility and your review profile decide whether the booking happens.
That is why a generic “healthcare marketing” template underperforms for dermatology. The medical side has steady, recession-resistant demand (skin cancer is the most common cancer in the US, and one in five Americans develop it). The cosmetic side is the growth engine, with the US medical aesthetics market on a 13.0% CAGR to $17.45 billion by 2031. We build for both, and every claim on this page is backed by a real source, listed at the bottom.
The case for doing this differently is not our opinion. It is what the data says, every figure sourced below.
One practice, two completely different buyers.
Dermatology is unusual because it runs a non-discretionary medical practice and a discretionary luxury practice off the same front desk. Medical derm is anchored by demand that never goes away: skin cancer is the most common cancer in the United States, an estimated 9,500 people are diagnosed every day, and the high-intent term “dermatologist near me” pulls 259,000 US searches a month at a modest $2.50 cost-per-click. People searching it are not browsing; they want an appointment.
Cosmetic derm is the margin and growth engine. The US medical aesthetics market is on a 13.0% CAGR, climbing from $9.46 billion in 2026 to $17.45 billion by 2031, and neuromodulators like Botox are the single most-performed minimally invasive procedure, with 9,883,711 treatments in 2024. The keywords reflect the higher value: “botox near me” runs 82,000 searches a month at a $5.00 CPC, roughly double the medical-derm term. We build a site and a campaign structure that serves both intents cleanly instead of forcing one message to do both jobs.
“Dermatologist near me” pulls 259,000 searches a month. The patient is ready; the only question is whether you’re the one they find.
Two buyers, two searches
Your review profile is the appointment.
For a stranger deciding who gets near their skin (or their face), reviews are the proof. BrightLocal’s consumer research shows that 97% of consumers read reviews for local businesses, and 68% will only use a business rated four stars or higher, up from 55% a year earlier. The bar is rising: a rating that cleared the threshold last year may not clear it now.
For dermatology, where the patient is choosing who treats a cancer screening or a $1,500 cosmetic procedure, a thin or stale review profile quietly caps your appointment volume no matter how much you spend on ads. We treat reviews as an owned asset with a steady, ethical engine for earning them, so the rating and the recency keep pace with the practice down the street.
Reviews come first, and the four-star bar is rising
68% of consumers will only use a local business rated four stars or higher, up from 55% a year earlier (BrightLocal).
Source: BrightLocal, Local Consumer Review Survey“Near me” is the default, and the local pack is protected.
Dermatology is a local business, and search behaves accordingly. For a practice, the map pack and your Google Business Profile are the most valuable real estate you can win, because that is where ready-to-book patients land when they search “dermatologist near me.”
Here is the part most marketers miss. As AI Overviews reshape search, you might expect the local provider search to get eaten by an AI answer. The opposite happened: BrightEdge tracked healthcare local and provider “near me” queries and found AI Overview coverage went from 100% in December 2023 to 0% in December 2025. Google pulled AI summaries off provider-finding searches. So while AI Overviews are absorbing informational and symptom traffic, the local pack and your reviews are more protected, not less, which makes local SEO the highest-confidence lever in this niche right now.
Google pulled AI Overviews off provider “near me” searches: 100% coverage in 2023 down to 0% in 2025. The local pack is protected.
Google removed the AI answer from local provider search
AI is eating the informational click, not the booking.
The informational side of dermatology (what a mole means, how to treat acne, whether a rash is serious) is exactly where AI summaries are absorbing traffic. Pew Research tracked real Google activity and found that when an AI summary appears, people click a traditional result only 8% of the time, versus 15% when no summary is present. If your patient-education content is your whole search strategy, that traffic is thinning.
The strategic read for a derm practice is precise: AI Overviews are pulling clicks off symptom and education queries while leaving local provider searches alone. So the play is to be the cited, credible source the AI answer reaches for on clinical questions, and to dominate the protected local pack on “dermatologist near me.” That means structured, verifiable content the answer layer can quote, clear entity and authority signals, and a reviews profile both Google and the AI layer can read. We build the practice to win both surfaces, not to bet everything on the one that is shrinking.
The informational click is shrinking
This hits symptom and education searches, not the local provider searches Google has protected.
Source: Pew Research Center, 2025Dermatology is the best-converting paid channel in healthcare.
Most healthcare verticals make a shaky case for Google Ads. Dermatology makes the cleanest one in the category. LocaliQ’s benchmarks show dermatology posted the highest average paid-search conversion rate of any healthcare specialty at 25.33%, and the largest year-over-year improvement, up 54%. It also delivers the lowest cost per lead among the subcategories at $18.54, against a healthcare-wide average of $66.02, with a dermatology CPC of $4.90.
That combination, a quarter of clicks converting at the lowest lead cost in the field, is unusual and worth pressing. The economics improve further when you split medical from cosmetic: medical-derm terms like “dermatologist near me” run a $2.50 CPC, while premium cosmetic and surgical terms run higher, reflecting the higher procedure value. We structure campaigns so the cheap, high-intent medical clicks fill the schedule and the premium cosmetic spend is pointed only at the procedures with the margin to justify it.
Dermatology converts paid search at 25.33%, the highest of any healthcare specialty, at the lowest cost per lead in the field, $18.54.
Highest conversion, lowest cost per lead
The lead you paid for cools by the minute.
Demand is only half the funnel. A cosmetic inquiry or a new-patient request is most winnable in the first few minutes, and dermatology practices routinely lose those leads to a slow front desk. The Lead Response Management Study found a 21-fold decrease in the odds of qualifying a web lead when first contact slips from 5 minutes to 30 minutes. That is not a healthcare-specific quirk; it is how inbound demand behaves everywhere, and it applies directly to derm intake and cosmetic consults.
For cosmetic in particular, where a single patient can be worth years of repeat treatments, a missed call or an unanswered form is the most expensive mistake in the funnel. We pair the demand we generate with fast, tracked intake so the leads you already paid for reach a person while they are still deciding. The cheapest patient you will ever book is the one who already raised their hand.
5 minutes versus 30 minutes
Current estimates are that one in five Americans will develop skin cancer in their lifetime. Skin cancer is the most common cancer in the United States.
American Academy of Dermatology
Dermatology had the highest average CVR this year at 25.33%, and the industries with the biggest improvements in CVR year over year were led by Dermatology, up 54%.
LocaliQ, Healthcare Search Advertising Benchmarks
Neuromodulator use increased by 4% in 2024, with 9,883,711 treatments performed. Neuromodulators such as Botox maintained their spot as the top minimally invasive treatment.
American Society of Plastic Surgeons, 2024 Statistics
Ready to grow the medical and the cosmetic side at once?
Tell us your service mix, your markets, and where appointments are leaking, and we’ll show you exactly where the demand is and how we’d win it: the protected local pack on “dermatologist near me,” the reviews that gate the booking, and the cosmetic campaigns pointed only at the procedures worth the spend. Senior people, transparent pricing, and reporting on booked appointments instead of vanity traffic.
Frequently asked
What does a dermatology marketing agency do?
Should a dermatology practice market medical and cosmetic services differently?
How much do dermatology Google Ads cost, and are they worth it?
How important are online reviews for a dermatology practice?
Will AI Overviews hurt my dermatology practice’s search traffic?
How fast do we need to respond to a new patient or cosmetic inquiry?
Every figure on this page comes from a primary platform, an independent study, or a named industry source. No competing-agency stats, no made-up numbers.
- Ahrefs Keywords Explorer (US): dermatology keyword volume and CPC
- LocaliQ / WordStream: Healthcare Search Advertising Benchmarks
- MarketsandMarkets: US Medical Aesthetics market
- American Academy of Dermatology: skin cancer statistics
- American Society of Plastic Surgeons: 2024 Statistics press release
- BrightLocal: Local Consumer Review Survey
- BrightEdge: Healthcare AI Evolution on Google (2023-2025)
- Pew Research Center: clicks when an AI summary appears (2025)
- Lead Response Management Study (Prof. James Oldroyd)
